DPIIT recognised startup Government of India
Startup India
Grevis Pharmaceuticals Private Limited - healthcare in Gurgaon, Haryana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹5.43 Cr
▲ 4% YoY
Net profit · FY 2025
₹26.57 Lakh
Net margin 4.9%
EBITDA · FY 2025
₹29.2 Lakh
EBITDA margin 5.4%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Employees · EPFO
3
Provident fund records
Directors on board
2
As per MCA filings
About Grevis Pharmaceuticals Private Limited
Data last updated:
Grevis Pharmaceuticals Private Limited is a private limited company based in Gurgaon, Haryana, India, recognised as a startup by DPIIT. It operates in the eye care and ophthalmology clinics segment of the healthcare sector. It was incorporated on 30 August 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999HR2017PTC070559. Its GSTIN is 06AAGCG9829G1ZB (Haryana).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Ashima Chawla and Ashwini Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Scf – 230 Second Floor Jmd Megapolis Sector – 48 Sohna Road Gurgaon, Haryana, India – 122001.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.43 Cr, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹26.57 Lakh (net margin 4.9%) and EBITDA of ₹29.2 Lakh (EBITDA margin 5.4%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 28% over five years.
The company has about 3 employees on its provident fund (EPFO) records.
Grevis Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-05-0038964). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website grevispharma.com.
Company details
CIN U74999HR2017PTC070559
Registration Number 070559
Incorporation Date 30 August 2017
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
MSME Classification Small
Udyam Registration UDYAM-HR-05-0038964
Key People
Ashima Chawla Director Ashwini Kumar Director Recognitions & Rankings of Grevis Pharmaceuticals
MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-HR-05-0038964
Contact details
Grevis Pharmaceuticals Private Limited's registered office is in Gurgaon, Haryana. Its website is grevispharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressScf – 230 Second Floor Jmd Megapolis Sector – 48 Sohna Road Gurgaon, Haryana, India – 122001
- IndustryHealthcare, Eye Care & Ophthalmology Clinics
To see the full contact details of Grevis Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Grevis Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Grevis Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Grevis Pharmaceuticals Private Limited, buy the company report.
Financials of Grevis Pharmaceuticals Private Limited
FY 2025 filings availableGrevis Pharmaceuticals Private Limited reported revenue of ₹5.43 Cr (up 4% YoY) for FY 2025.
Revenue · FY 2025
₹5.43 Cr ▲ 4%
Net profit · FY 2025
₹26.57 Lakh margin 4.9%
EBITDA · FY 2025
₹29.2 Lakh margin 5.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 4%
3 years · compounded
▲ 12%
5 years · compounded
▲ 28%
EBITDA CAGR growth
1 year
▲ 22%
3 years · compounded
▲ 16%
5 years · compounded
▲ 35%
Revenue has grown at a compounded annual rate (CAGR) of 28% over five years, including 4% growth in the latest year. EBITDA rose 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹29.2 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹26.57 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.4% | ||||
| Net Profit Margin | 4.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Grevis Pharmaceuticals Private Limited, buy the company report.
Board of directors of Grevis Pharmaceuticals Private Limited
Grevis Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashima Chawla | Director | 30 Aug 2017 | 9 Years 1 Months | Current |
| Ashwini Kumar Also directs: Rynel Clifton Pharma Private Limited | Director | 30 Aug 2017 | 9 Years 1 Months | Current |
Peer comparison
Grevis Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Healthcare industry (Eye Care, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Torchem Pharmaceuticals Private Limited | ₹5.49 Cr (FY 2025) | 301.0% | Delhi, India | |||
| Emdrix Pharmaceuticals Private Limited | ₹5.48 Cr (FY 2017) | 73.0% | Bangalore, Karnataka, India | |||
| Grevis Pharmaceuticals Private Limitedthis company | ₹5.43 Cr (FY 2025) | ₹26.57 Lakh | 4.9% | 4.0% | 3 | Gurgaon, Haryana, India |
| Yati Pharmaceuticals Private Limited | ₹5.39 Cr (FY 2025) | 16.0% | Muzaffarnagar, Uttar Pradesh, India | |||
| Biosync Pharmaceuticals Private Limited | ₹5.38 Cr (FY 2025) | -1.0% | Chandigarh, India |
To see the full peer comparison of Grevis Pharmaceuticals Private Limited, buy the company report.
Auditor
Grevis Pharmaceuticals Private Limited is audited by A A R Y A & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A A R Y A & ASSOCIATES | FY 2022 | 020281N |
Shareholding
The shareholding of Grevis Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Grevis Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Grevis Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Grevis Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Grevis Pharmaceuticals Private Limited has a workforce of 3 employees on its EPFO records as of Apr 02, 2024, across 1 active EPFO establishment.
Employee count
3
Active EPFO establishments
1
Employee growth
-40%
GST
Grevis Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAGCG9829G1ZB | Haryana | Active | 02 May 2018 |
To see the full GST registrations and return filing status of Grevis Pharmaceuticals Private Limited, buy the company report.
Recent activity
Grevis Pharmaceuticals Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Ashima Chawla was appointed as Director on 30 Aug 2017.
AGM
Grevis Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Grevis Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Appointed
Ashima Chawla was appointed as Director.
Appointed
Ashwini Kumar was appointed as Director.
Incorporation
30 Aug 2017
Grevis Pharmaceuticals Private Limited was registered on 30 Aug 2017 with Roc Delhi & aged 9 years 1 month as per MCA records.
Frequently asked questions
Grevis Pharmaceuticals is an active private limited company based in Gurgaon, Haryana, India. The company works in eye care and ophthalmology clinics, within the healthcare industry. It was incorporated on 30 August 2017 (9+ years old) and is registered under CIN U74999HR2017PTC070559.
Grevis Pharmaceuticals has 2 current directors:
- Ashima Chawla - Director
- Ashwini Kumar - Director
The latest financial statements of Grevis Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Grevis Pharmaceuticals is 06AAGCG9829G1ZB, registered in Haryana.
The CIN (Corporate Identification Number) of Grevis Pharmaceuticals is U74999HR2017PTC070559. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Grevis Pharmaceuticals was incorporated on 30 August 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Grevis Pharmaceuticals by revenue are Torchem Pharmaceuticals Private Limited, Emdrix Pharmaceuticals Private Limited, Yati Pharmaceuticals Private Limited, Biosync Pharmaceuticals Private Limited, all in the Healthcare industry (Eye Care, Pharmaceuticals), with the same principal business activity (wholesale trading).
Ashima Chawla was appointed as Director on 30 Aug 2017. Ashwini Kumar was appointed as Director on 30 Aug 2017.
Yes, Grevis Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Grevis Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-HR-05-0038964).
Grevis Pharmaceuticals can be reached through the website grevispharma.com. Its registered office is in Gurgaon, Haryana, India.